Cargando…
357. High Rate of Adverse Events in Patients Receiving Oral Antimicrobials Under a COpAT Monitoring Protocol
BACKGROUND: Oral linezolid (LZD), trimethoprim sulfamethoxazole (SXT), voriconazole (VRC), and itraconazole (ITC) are used often for prolonged durations and are associated with an array of adverse events (AEs). Establishing specific protocols for monitoring such courses of Complex Outpatient Antibio...
Autores principales: | Sawey, Ciara, Burgoyne, Colleen, Winbush, Angelina, Temple, Craig, Qualls, Brandon W, Munsiff, Sonal, Yamshchikov, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678478/ http://dx.doi.org/10.1093/ofid/ofad500.428 |
Ejemplares similares
-
Taking the route less traveled: on the way to COpAT
por: Pertzborn, Margaret, et al.
Publicado: (2023) -
342. Evaluation of Patient Satisfaction with Outpatient Parenteral Antibiotic Therapy (OPAT) at a University Medical Center
por: Sawey, Ciara, et al.
Publicado: (2023) -
Exploring patient acceptance of research within complex oral and IV outpatient parenteral antimicrobial therapy (COpAT) networks
por: Rawson, Timothy M, et al.
Publicado: (2022) -
619. Current State of Infectious Diseases Pharmacist OPAT/COpAT Practice in the United States
por: Rivera, Christina G, et al.
Publicado: (2021) -
333. How the COVID-19 Pandemic Accelerated Development of our Complex Outpatient Oral Antimicrobial Therapy (COpAT) Program
por: Juskowich, Joy J, et al.
Publicado: (2023)